Cancer: Closing the door on KRAS-mutant lung cancer.
Megan
M
Cully
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*
D000970:Antineoplastic Agents; C117307:KRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)